Currently, there are 359.56M common shares owned by the public and among those 359.18M shares have been available to trade.
The company’s stock has a 5-day price change of 1.44% and 10.06% over the past three months. CME shares are trading 13.68% year to date (YTD), with the 12-month market performance up to 14.51% higher. It has a 12-month low price of $190.70 and touched a high of $249.02 over the same period. CME has an average intraday trading volume of 2.02 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.63%, 3.66%, and 11.76% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of CME Group Inc (NASDAQ: CME) shares accounts for 88.84% of the company’s 359.56M shares outstanding.
It has a market capitalization of $86.27B and a beta (3y monthly) value of 0.57. The stock’s trailing 12-month PE ratio is 25.17, while the earnings-per-share (ttm) stands at $9.51. The company has a PEG of 5.19 and the debt-to-equity ratio at 0.14. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.48% over the week and 1.78% over the month.
Earnings per share for the fiscal year are expected to increase by 9.52%, and 1.83% over the next financial year. EPS should shrink at an annualized rate of 4.85% over the next five years, compared to 9.19% over the past 5-year period.
Looking at the support for the CME, a number of firms have released research notes about the stock. Redburn Atlantic stated their Neutral rating for the stock in a research note on October 08, 2024, with the firm’s price target at $244. RBC Capital Mkts coverage for the CME Group Inc (CME) stock in a research note released on September 27, 2024 offered a Sector Perform rating with a price target of $235. TD Cowen was of a view on September 26, 2024 that the stock is Hold, while BofA Securities gave the stock Underperform rating on September 03, 2024, issuing a price target of $212- $177. JP Morgan on their part issued Underweight rating on June 21, 2024.
